Isocitrate Dehydrogenase (IDH) Inhibitors Market – Latest Research, Industry Analysis, Driver, Trends, Business Overview, Key Value, Demand And Forecast to 2033

 The market for isocitrate dehydrogenase (IDH) inhibitors worldwide has a market value of US$ 1.7 billion in 2022 and is anticipated to grow at a CAGR of 33% from 2023 to 2033 to reach US$ 39.16 billion.

Additionally, the development of more potent and selective IDH inhibitors, as well as the expansion of their use into other cancer types, is expected to further contribute to the growth of the market. Bayer and Agios Pharmaceuticals are among the key players in the IDH inhibitors market, with their respective drugs BAY 1436032 and ivosidenib being approved by the US FDA for the treatment of IDH-mutated cancers. These drugs have shown promising results in clinical trials, including high response rates and extended survival in patients with AML.

The IDH inhibitors market is a rapidly growing field with significant potential for the treatment of several types of cancer. Continued research and development efforts, as well as the development of new drugs and treatment strategies, are expected to contribute to the growth of the market.

Get a PDF Sample with Latest Market Insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-16847

Key Takeaways from the Market Study

  • The global Isocitrate dehydrogenase (IDH) inhibitors market is expected to grow with a 33% CAGR during 2023 to 2033.
  • Oral route of administration is expected to hold 49% of the market share in 2023 for Isocitrate dehydrogenase (IDH) inhibitors market.
  • North America is expected to possess 46% market share for Isocitrate dehydrogenase (IDH) inhibitors market in 2023.
  • Europe Isocitrate dehydrogenase (IDH) inhibitors market size is expected to possess 43% market share in 2023.

“The development of combination therapies and alternative treatment strategies is being explored to further optimize the clinical benefit of IDH inhibitors. This, in turn, is fueling the growth of IDH inhibitors market.” states an FMI analyst

Competitive Landscape

Key players in the isocitrate dehydrogenase (IDH) inhibitors market are Bayer, Agios Pharma, Daiichi Sankyo, Ohm Oncology, Celgene, Philogen S.p.A., Tragara, Aslan Pharmaceuticals, Pfizer, Inc. and Sun Pharmaceutical Industries Ltd.

  • Bayer is collaborating with other pharmaceutical companies, such as Agios Pharmaceuticals, in the development of IDH inhibitors. The two companies have a joint development and commercialization agreement for ivosidenib (AG-120), an oral small molecule inhibitor of the mutated IDH1 enzyme, which has been approved by the US FDA for the treatment of relapsed or refractory acute myeloid leukemia (AML) with an IDH1 mutation.
  • Agios’ Pharma lead IDH inhibitor candidate is ivosidenib (AG-120), an oral small molecule inhibitor of the mutated IDH1 enzyme. Ivosidenib works by inhibiting the production of the oncometabolite 2-hydroxyglutarate (2-HG) and inducing differentiation of leukemia cells. Ivosidenib has been approved by the US FDA for the treatment of relapsed or refractory acute myeloid leukemia (AML) with an IDH1 mutation.

For more Report Customization, connect with us at @
https://www.futuremarketinsights.com/customization-available/rep-gb-16847

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Isocitrate dehydrogenase (IDH) inhibitors market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Type (IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor, Peptides, Small Molecule, Others) Molecule Types (Monoclonal Antibody, Peptides, Small Molecules, Others) Route of Administration (Oral, Parenteral, Subcutaneous) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)

About the Healthcare at Future Market Insights

The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 Billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Last few days to get reports at discounted prices, offer expires soon!
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16847

Key Segments Profiled in the Isocitrate Dehydrogenase (IDH) Inhibitors Industry Survey

Type:

  • IDH1 Mutant Medullary Malignant Tumor
  • IDH2 Mutant Medullary Malignant Tumor
  • Peptides
  • Small Molecule
  • Others

Molecule Types:

  • Monoclonal Antibody
  • Peptides
  • Small Molecules
  • Others

Route of Administration:

  • Oral
  • Parenteral
  • Subcutaneous

Comments

Post a Comment

Popular posts from this blog

Cardboard Flask Market Insights By Type, Industry, Application & End-User | FMI

 Beverage industry which is growing continuously has led to developments and innovations in the cardboard flask market. Countries that have high consumption of tea and coffee such as the USA, United Kingdom, China, Japan & India might impact the demand for cardboard flask. Cardboard flasks might not be predominant when it comes to the sale of these hot beverages in the brick and mortar store but E-commerce has hiked the demand for cardboard flask. The convenience and ease of ordering the hot beverages at their workplace and homes with advent of digitalization in developing countries such as India and China is likely to augment the demand for the cardboard flask market. Compared to its counterpart which is a traditional flask which were used by the brand owners to deliver the beverage to its customers, the cardboard flask provides more pros since its cuts down the cost of collecting and cleaning them. Thus, this is likely to positively impact the growth of the cardboard flask market
Read more

Veterinary Ultrasound Scanners Market Size, Share, Industry Analysis, Future Growth, Segmentation, Competitive Landscape, Trends and Forecast 2022 to 2028

  Future Market Insights (FMI) offers a 10-year forecast on the global  veterinary ultrasound scanners market.  The primary objective of the report is to offer updates and information related to market opportunities in the veterinary ultrasound scanners market. By the end of 2028, the market for veterinary ultrasound scanners, which is presently valued at US$ 190 Million, is expected to have grown at a CAGR of 4% and be worth US$ 240 Million. Future Market Insights foresees a comparison and review study of the dynamics of the market for veterinary ultrasound scanners, which is primarily influenced by a variety of industry aspects as well as a few distinct influences on therapeutic views that foster industry innovation. The market is significantly impacted by industry, macroeconomic, and inventive aspects. Market changes include wireless streaming on IBEX® PRO and LITE models and the creation of goods like the OsiriX® viewer for dogs, which enables precise and repeatable. Visit Fo
Read more

Companion Diagnostics Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast to 2022 to 2032 | Says FMI Analyst

 The global  Companion Diagnostics Market  is projected CAGR of 7.1% during the forecast period, the global companion diagnostics market is expected to generate sales of around US$ 5152.064939 million by 2032, up from US$ 2452.653722 million in 2022. Companion diagnostics is used to determine who would benefit from treatment, and the demand for it is increasing as it helps to identify if someone cannot be cured, but can also be harmed by the use of a specific drug used to treat their ailment. Furthermore, the growth of the companion diagnostics market is being propelled by technological advancements, which have brought about significant changes in the overall method of disease treatment. Request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1255 Companion Diagnostics Market: Segmentation Valuable information covered in the FMI’s Companion Diagnostics market report has been segregated into key segments and sub-segments. By Application
Read more